BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21606765)

  • 21. Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative pain.
    Liu W; Dutta S; Kearns G; Awni W; Neville KA
    J Clin Pharmacol; 2015 Feb; 55(2):204-11. PubMed ID: 25196888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.
    Cone EJ; DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R
    J Anal Toxicol; 2015 Sep; 39(7):510-8. PubMed ID: 25962610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overdose deaths demand a new paradigm for opioid rotation.
    Webster LR; Fine PG
    Pain Med; 2012 Apr; 13(4):571-4. PubMed ID: 22458858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers.
    Valtier S; Bebarta VS
    J Anal Toxicol; 2012 Sep; 36(7):507-14. PubMed ID: 22782534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Toxic Breast-feeding?
    Schultz ML; Kostic M; Kharasch S
    Pediatr Emerg Care; 2019 Jan; 35(1):e9-e10. PubMed ID: 28067687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.
    Carter NJ; Keating GM
    CNS Drugs; 2010 Apr; 24(4):337-61. PubMed ID: 20297858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled-release opioids and alcohol.
    Darke AC
    CMAJ; 2006 Jan; 174(3):352. PubMed ID: 16446485
    [No Abstract]   [Full Text] [Related]  

  • 28. Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.
    Hall PB
    W V Med J; 2014; 110(6):6-10. PubMed ID: 25651658
    [No Abstract]   [Full Text] [Related]  

  • 29. Survey draws attention to HYDROmorphone knowledge deficits.
    Alta RN; 2012; 68(3):12-3. PubMed ID: 23162986
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of an opioid taper algorithm in hematopoietic progenitor cell transplant recipients.
    Parran L; Pederson C
    Oncol Nurs Forum; 2002; 29(1):41-50. PubMed ID: 11817492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cigarette smoking on hydrocodone efficacy in chronic pain patients.
    Ackerman WE
    J Ark Med Soc; 2012 Oct; 109(5):90-3. PubMed ID: 23061240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of hydrocodone and hydromorphone interference in the GC-MS detection of morphine and codeine.
    Brooks KE; Smith NB
    J Anal Toxicol; 1996; 20(4):269-70. PubMed ID: 8835667
    [No Abstract]   [Full Text] [Related]  

  • 33. Benzhydrocodone/acetaminophen (Apadaz) for pain.
    Med Lett Drugs Ther; 2019 Jul; 61(1576):110-112. PubMed ID: 31381547
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydrocodone extended-release: pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy.
    Gould HJ; Paul D
    Pharmacol Res; 2015 Jan; 91():99-103. PubMed ID: 25301538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone].
    Sabatowski R; Giesecke T
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():119-24. PubMed ID: 17955789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxycodone as a component of multimodal analgesia for lactating mothers after Caesarean section: relationships between maternal plasma, breast milk and neonatal plasma levels.
    Seaton S; Reeves M; McLean S
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):181-5. PubMed ID: 17550483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum daily dose of hydrocodone.
    Nerenberg DM; Fudin J
    Am J Health Syst Pharm; 2010 Oct; 67(19):1588-9. PubMed ID: 20852155
    [No Abstract]   [Full Text] [Related]  

  • 38. Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
    Ruan X; Bumgarner GW; Labrie-Brown C; Kaye AD
    Clin J Pain; 2016 Dec; 32(12):1105-1106. PubMed ID: 26889610
    [No Abstract]   [Full Text] [Related]  

  • 39. Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone.
    Graziani M; Nisticò R
    Pharmacol Res; 2016 Jun; 108():31-38. PubMed ID: 27107788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.